References
- Messina JL, Fenstermacher DA, Eschrich S et al. 12-chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci. Rep. 2, 765 (2012).
- Cheson BD, Kerr DJ, Kris MG et al. 2011 top game changers in oncology. Medscape 23 November 2011.
- Weber JS, Kähler KC, Hauschild A. Management of immune-related adverse events and kinetics of response with ipilimumab. J. Clin. Oncol. 30(21), 2691–2697 (2012).